Charles River Analyst Price Targets

Charles River Laboratories International Inc

CRLNYSE

$292.84

-1.60-0.54%

al cierre: Sep 25, 5:00 PM EST

$292.84

N/A

After hour: Sep 25, 4:00 PM EST

Wall Street analyst price targets and consensus rating for Charles River (CRL).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

12Buy

7Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$261Upside to Avg. PT-10.9%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Deutsche Bank	Justin Bowers	PT Raise	Buy	$300→$320
Sep 25, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$300→$325
Sep 25, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$320→$330
Sep 25, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$282→$322
Sep 25, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$300→$330
Sep 25, 2026	Mizuho	Ann Hynes	PT Raise	Neutral	$264→$295
Sep 25, 2026	Baird	Eric Coldwell	PT Raise	Outperform	$291→$334
Sep 11, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$300→$320
Aug 10, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$235→$300
Aug 7, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$260→$300
Aug 6, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$215→$282
Aug 6, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$260→$300
Aug 6, 2026	JP Morgan	Casey Woodring	Upgrade	Neutral→Overweight	$180→$310
Jul 20, 2026	CLSA	Michael Luo	Downgrade	Outperform→Hold	$219
Jul 13, 2026	Mizuho	Ann Hynes	PT Raise	Neutral	$192→$230
Jul 9, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$220→$260
Jun 17, 2026	Morgan Stanley	Ricky Goldwasser	Upgrade	Equal-Weight→Overweight	$185→$220
May 29, 2026	CLSA	Michael Luo	Upgrade	Hold→Outperform	$167→$219
May 8, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$210→$220
May 8, 2026	Evercore ISI Group	Ross Muken	PT Raise	Outperform	$200→$220